Website
News25/Ratings0
Latest news
25 items- SECBIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - BIMI Holdings Inc. (0001213660) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. The company's market cap stands at $11.4 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 40.0% to $3.99. The market value of their outstanding shares is at $88.6 million. ASLAN Pharma (NASDAQ:ASLN) stock increased by 18.51% to $0.37. The market value of their outstanding shares is at $8.3 million. Talphera (NASDAQ:TLPH) shares increased by 15.18% to $0.9. The company's market cap stands at $15.2 million. Geovax Labs (NASDAQ:GOVX) stock rose 13.15% to $2.15. The market value of their outstanding shares is at $5.4 million. SAB Biotherapeutics (NASDAQ:SABS)
- NEWSWhy Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint. Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS). AMMO shares dipped 19.1% to $2.0306 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Interactive Strength Inc. (NASDAQ:TRNR) shares climbed 148% to $7.07 after dipping 19% on Friday. Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% to $0.32 after the company announced safety and efficacy da
- NEWSWhy Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving PremarketShares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia. Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity. Interactive Strength Inc. (NASDAQ:TR
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 77.4% to $6.19 during Monday's pre-market session. The company's market cap stands at $3.5 million. ENDRA Life Sciences (NASDAQ:NDRA) shares moved upwards by 35.9% to $0.14. The company's market cap stands at $2.4 million. Venus Concept (NASDAQ:VERO) stock increased by 22.86% to $1.15. The company's market cap stands at $7.3 million. Tharimmune (NASDAQ:THAR) shares moved upwards by 19.4% to $4.0. The company's market cap stands at $3.1 million. TRACON Pharma (NASDAQ:TCON) stock moved upwards by 19.04% to $1.5. The market value of their outstanding shares is at $4.0 million. Kineta (NASDAQ:KA) shares moved upwards by
- NEWSWhy AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day SessionShares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for a loss of 1 cent per share. The company reported quarterly sales of $40.42 million topping estimates of $37.90 million, according to data from Benzinga Pro. AMMO shares dipped 19.1% to $2.0306 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares jumped 345% to $6.06. SRIVARU Holding Limited (NASDAQ:SVMH) gained 150% to $0.3852 after the company announced it will begin accepting paid reserva
- INSIDERDirector Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)4 - BIMI Holdings Inc. (0001213660) (Issuer)
- SECBIMI International Medical Inc. filed SEC Form 8-K: Leadership Update8-K - BIMI Holdings Inc. (0001213660) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's After-Market SessionGainers FibroGen (NASDAQ:FGEN) stock moved upwards by 24.4% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $152.1 million. Candel Therapeutics (NASDAQ:CADL) stock increased by 8.12% to $9.05. The company's market cap stands at $269.2 million. RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 7.53% to $4.28. The market value of their outstanding shares is at $149.3 million. Gritstone Bio (NASDAQ:GRTS) shares increased by 7.24% to $0.79. The market value of their outstanding shares is at $85.4 million. Scholar Rock Holding (NASDAQ:SRRK) shares rose 6.96% to $10.14. The company's market cap stands at $808.7 million. Novo Integrated
- SECBIMI International Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - BIMI Holdings Inc. (0001213660) (Filer)
- NEWSBIMI Receives Notification Of Delinquency Compliance From NasdaqBIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on May 17, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to its failure to timely file its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (the "SEC"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended December 31, 2023, it is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing
- SECBIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - BIMI Holdings Inc. (0001213660) (Filer)
- PRBIMI Announces Receipt of a Delinquency Compliance Alert Notice from NasdaqNew York, May 20, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on May 17, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to its failure to timely file its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (the "SEC"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended December 31, 2023, it is not in compliance with Nasdaq's contin
- NEWSBIMI International Medical Announces Receipt Of Delinquency Compliance Alert Notice From Nasdaq
- SECBIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - BIMI Holdings Inc. (0001213660) (Filer)
- PRBIMI Announces Receipt of a Delinquency Compliance Alert Notice from NasdaqNew York, April 23, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on April 19, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers VolitionRX (AMEX:VNRX) shares rose 33.6% to $0.8 during Tuesday's regular session. The market value of their outstanding shares is at $65.7 million. Palisade Bio (NASDAQ:PALI) stock increased by 29.81% to $6.4. The company's market cap stands at $5.4 million. Kintara Therapeutics (NASDAQ:KTRA) shares increased by 24.67% to $0.14. The market value of their outstanding shares is at $5.5 million. Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 23.88% to $1.55. The company's market cap stands at $6.8 million. BIMI Intl Medical (NASDAQ:BIMI) stock moved upwards by 23.21% to $1.38. The market value of their outstanding shares is at $19.3 million. NKGen Biotech (NASDAQ:NKGN)
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) shares moved upwards by 8.4% to $0.65. The market value of their outstanding shares is at $23.2 million. Mustang Bio (NASDAQ:MBIO) shares rose 7.78% to $0.4. The market value of their outstanding shares is at $4.1 million. BIMI Intl Medical (NASDAQ:BIMI) shares moved upwards by 7.46% to $1.44. The market value of their outstanding shares is at $20.1 million. Allarity Therapeutics (NASDAQ:ALLR) stock increased by 7.14% to $1.65. The company's market cap stands at $3.2 million. China SXT Pharmac
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers INVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release, Q4 earnings came out yesterday. Clene (NASDAQ:CLNN) shares moved upwards by 40.8% to $0.44. The market value of their outstanding shares is at $56.0 million. Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 31.76% to $0.22. The market value of their outstanding shares is at $12.1 million. Vanda Pharma (NASDAQ:VNDA) stock moved upwards by 26.91% to $5.14. The company's market cap stands at $295.7 million. Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 23.62% to $2.25
- NEWSBIMI Holdings Sees FY23 Net Loss ~$14.9M; Sees FY23 Revenue $18.5M
- SECSEC Form NT 10-K filed by BIMI International Medical Inc.NT 10-K - BIMI Holdings Inc. (0001213660) (Filer)
- SECBIMI International Medical Inc. filed SEC Form 8-K: Other Events8-K - BIMI Holdings Inc. (0001213660) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's After-Market SessionGainers Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings report came out today. OpGen (NASDAQ:OPGN) shares moved upwards by 66.61% to $0.79. The market value of their outstanding shares is at $7.9 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 11.62% to $1.92. The company's market cap stands at $7.0 million. Vaxxinity (NASDAQ:VAXX) shares moved upwards by 7.99% to $0.72. The company's market cap stands at $90.8 million. Unity Biotechnology (NASDAQ:UBX) stock rose 7.39% to $1.7. The market value of their outstanding shares is at $28.4 mi
- INSIDERNew insider Smith Symington Wei claimed ownership of 3,456 shares (SEC Form 3)3 - BIMI Holdings Inc. (0001213660) (Issuer)
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 55.9% to $0.07 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.8 million. CASI Pharmaceuticals (NASDAQ:CASI) shares rose 47.68% to $7.51. The company's market cap stands at $100.0 million. Regenxbio (NASDAQ:RGNX) stock moved upwards by 37.17% to $29.3. The market value of their outstanding shares is at $1.3 billion. Apogee Therapeutics (NASDAQ:APGE) stock increased by 36.08% to $56.8. The company's market cap stands at $2.7 billion. Tiziana Life Sciences (NASDAQ:TLSA) shares increased by 19.96% to $0.56. The market value of their outstanding shares is at $56.5 million. Eyenovia (N